← Leaderboards
Natalie J Torok
Veterans Admin Palo Alto Health Care Sys
$8,762,870
Attributed
$10,580,763
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,580,763 · 8
VA$0 · 1
By mechanism
R01$6,684,306 · 3
T32$2,414,112 · 1
K08$673,345 · 1
R21$352,665 · 1
R56$304,335 · 1
R03$152,000 · 1
Top collaborators
- Gino A Cortopassi5 shared
- Anson W Lowe4 shared
- Eric Sibley4 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPathway InteractionsSignal TransductionHepatocyteIn VivoLiverMediatingProductionBaseInjuryCollagenInflammatoryFibrosisNadph OxidaseLinkInflammationPlayPhagocytosisApoptoticEventHepatic Stellate CellLiver InjuryMorbidity - Disease RatePathogenesis
Grant awards (46)
Matrix in pre-cirrhotic HCC$571,139
R01 · FY2025 · CA · contact PI
Training Grant in Academic Gastroenterology$394,117
T32 · FY2025 · DK · contact PI
The role of extracellular matrix in primary sclerosing cholangitis$0
I01 · FY2025 · VA · contact PI
Matrix in pre-cirrhotic HCC$546,474
R01 · FY2024 · CA · contact PI
Training Grant in Academic Gastroenterology$343,308
T32 · FY2024 · DK · contact PI
Matrix in pre-cirrhotic HCC$570,193
R01 · FY2023 · CA · contact PI
Training Grant in Academic Gastroenterology$345,108
T32 · FY2023 · DK · contact PI
Novel sterile inflammatory pathways in alcoholic hepatitis$0
I01 · FY2023 · VA · contact PI
Targeting Shc to reduce inflammation and fibrosis in the aging liver$375,549
R01 · FY2022 · AG · contact PI
Diabetes and extracellular matrix in NASH$304,335
R56 · FY2022 · DK · contact PI
Novel sterile inflammatory pathways in alcoholic hepatitis$0
I01 · FY2022 · VA · contact PI
Targeting Shc to reduce inflammation and fibrosis in the aging liver$368,757
R01 · FY2021 · AG · contact PI
Training grant in academic gastroenterology$352,518
T32 · FY2021 · DK · contact PI
Novel sterile inflammatory pathways in alcoholic hepatitis$0
I01 · FY2021 · VA · contact PI
Targeting Shc to reduce inflammation and fibrosis in the aging liver$374,324
R01 · FY2020 · AG · contact PI
Training grant in academic gastroenterology$347,129
T32 · FY2020 · DK · contact PI
Novel sterile inflammatory pathways in alcoholic hepatitis$0
I01 · FY2020 · VA · contact PI
Targeting Shc to reduce inflammation and fibrosis in the aging liver$370,517
R01 · FY2019 · AG · contact PI
Training grant in academic gastroenterology$321,398
T32 · FY2019 · DK · contact PI
AGEs/RAGE in Progressive NASH$310,500
R01 · FY2019 · DK · contact PI
Targeting Shc to reduce inflammation and fibrosis in the aging liver$371,200
R01 · FY2018 · AG · contact PI
Training grant in academic gastroenterology$310,534
T32 · FY2018 · DK · contact PI
AGEs/RAGE in Progressive NASH$310,500
R01 · FY2018 · DK · contact PI
NADPH oxidase inhibition in NASH$160,918
R21 · FY2018 · DK · contact PI
AGEs/RAGE in Progressive NASH$353,250
R01 · FY2017 · DK · contact PI
NADPH oxidase inhibition in NASH$191,747
R21 · FY2017 · DK · contact PI
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease$0
I01 · FY2017 · VA · contact PI
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease$0
I01 · FY2017 · VA · contact PI
AGEs/RAGE in Progressive NASH$353,250
R01 · FY2016 · DK · contact PI
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease$0
I01 · FY2016 · VA · contact PI
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease$0
I01 · FY2015 · VA · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$310,199
R01 · FY2014 · DK · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$194,375
R01 · FY2014 · DK · contact PI
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease$0
I01 · FY2014 · VA · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$299,341
R01 · FY2013 · DK · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$310,759
R01 · FY2012 · DK · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$311,479
R01 · FY2011 · DK · contact PI
Phagocytosis and NOX2 in Liver Fibrogenesis$382,500
R01 · FY2010 · DK · contact PI
Apoptosis and Liver Fibrogenesis$124,549
K08 · FY2009 · DK · contact PI
The Role of NOX2 in Liver Fibrosis$76,000
R03 · FY2009 · DK · contact PI
Apoptosis and Liver Fibrogenesis$49,680
K08 · FY2009 · DK · contact PI
Apoptosis and Liver Fibrogenesis$124,549
K08 · FY2008 · DK · contact PI
The Role of NOX2 in Liver Fibrosis$76,000
R03 · FY2008 · DK · contact PI
Apoptosis and Liver Fibrogenesis$124,549
K08 · FY2007 · DK · contact PI
Apoptosis and Liver Fibrogenesis$125,629
K08 · FY2006 · DK · contact PI
Apoptosis and Liver Fibrogenesis$124,389
K08 · FY2005 · DK